Deutsch
A A A
Bereichsnavigation

Previous
RHÖN-KLINIKUM AG | 04/28/2011

Results Press Conference in Frankfurt/Main on 28 April 2011

Results for financial year 2010

  • Further 13.4% increase in patient treatments is proof of the trust in the high quality of medical care offering.
  • Growth in revenues of 9.9% and in earnings of 10.2% in 2010 demonstrate the sustainability of growth course.
  • Occupation of new buildings in Gießen and Marburg in the first quarter of 2011. The investment commitments there – € 260 million from shareholder funds – were fully met. Gießen and Marburg are proof of investment capability and innovative strength.

Q1 2011 results

  • Continued rise in patient numbers by 69,839 cases or 13.7% to a total of 579,632 cases (previous year: 509,793 cases) underscores our good start into the new financial year.
  • Revenues climbed by 3.7% to reach € 647.2 million.
  • Net consolidated profit rose by € 3.7 million or 10.8% to reach € 38.0 million.
  • EBITDA rose by € 5.7 million or 7.8% to reach € 78.8 million.
  • EBIT improved by € 3.8 million or 8.1% to € 50.6 million.

Forecast for the further course of 2011

The Company confirms its forecast for 2011. Despite a challenging environment, the Company expects to generate revenues of roughly € 2.65 billion, an EBITDA of € 340 million and a net consolidated profit of approximately € 160 million, with the last two figures potentially fluctuating within a range of plus or minus 5%.

At its annual Results Press Conference today, the Board of Management of RHÖN-KLINIKUM AG confirmed the trend figures already published in February. “We can look back on a successful financial year 2010. “Patient numbers have grown once again“, said Wolfgang Pföhler, chairman of the Board of Management of RHÖN-KLINIKUM AG. “We are proud of the achievement of our employees and facilities. The growing demand for our healthcare services is proof of the trust people put in the high quality of our medical offering. We have succeeded in continuing our growth in both the outpatient and inpatient area. Our revenue and earnings targets were met as expected. We once again succeeded in expanding our market share in 2010. Our long-standing facilities report organic growth well above the emerging national average. At the same time we stick to our policy of investing the lion’s share of our corporate profit in our hospitals and MVZs, – some 70% of that profit is reinvested. That makes our investment ratio significantly higher than that of any public operator. The reliability of our business model was once again demonstrated. We can thus present a thoroughly positive result for financial year 2010”, Pföhler said.

Results for financial year 2010

In 2010, a total of more than two million patients were treated in the Group’s facilities. During the same period, revenues rose to € 2.55 billion. Net consolidated profit increased as forecast by 10.2% to € 145.1 million. Compared with last year, EBITDA was raised by 8.2% to € 307.3 million and EBIT by 8.7% to € 197.9 million. Operating cash flow saw an increase of 7.4% to € 255.9 million. 

The 13.4% rise in patient treatments was “proof of the great trust in the quality of our work”. With growth in revenues of 9.9% and in earnings of 10.2% in 2010, RHÖN-KLINIKUM AG moreover demonstrated the sustainability of its growth course – also in times of crisis. Pföhler gave assurance that this “reliable” course would also be “steadfastly” maintained in the new financial year.

On 8 June 2011, the Board of Management and the Supervisory Board will propose a dividend of € 0.37 (previous year: € 0.30) per ordinary non-par share with dividend entitlement (DE 0007042301; 138,232,000 non-par shares).

Jobs in 2010

As at 31 December 2010, RHÖN-KLINIKUM AG employed a total of 38,058 people in ten federal states. 
That is 1176 more than in the previous year. Above all doctors and nursing staff were added. In many regions, the Group’s facilities have come to be amongst the largest employers.

Q1 2011 results

The Management is pleased with the start the Company has made into financial year 2011. Already in the first three months, the Group treated 579,632 patients (+ 13.7%). Revenuesrose to € 647.2 million (+3.7%). Net consolidated profit rose 10.8% to reach € 38.0 million.

EBITDA climbed to € 78.8 million (+ 7.8%). EBIT stood at € 50.6 million, which translates into a rise of 8.1% versus the previous year’s level. As at 31 March 2011, the Group had 38,174employees. 

“The good first-quarter figures provide a very good starting point for reliably reaching our forecast for full-year 2011”, said Dr. Erik Hamann, the Company’s CFO.

To major projects were already successfully concluded in the first quarter. At the University Hospital of Gießen and Marburg two new buildings were put into service. At both sites the moves were completed without any incidents.

Outlook for 2011:

Securing the future sustainability of good medical care is one of the key aims pursued by the Group. Demographic trends and the related growing need for high-quality medical care for the elderly present new challenges for the healthcare system. “We are committed to meeting these needs by creating medical care offerings tailored to the individual needs of patients. We have starting doing this by strengthening our medical care networks within our Group, for example in acute geriatrics. 

The groundwork for this has been laid with the acquisition of the Salze Klinik hospital and the integration of a geriatric focus within our hospital network – an outstanding medical concept in which we are once again setting standards nationally. We are forging ahead with efforts to implement viable and path-breaking service offerings. 

At the same time, we continue to be committed to seeing through our development from classic hospital operator to integrated healthcare provider. The emerging structural transformation shows that we have come a good way towards successfully completing the process begun two years ago: advances in medicine and medical technology are giving rise to more and more opportunities for outpatient treatment. There is hardly any better example of how inpatient services are thus being shifted into the outpatient segment than the specialist field of ophthalmology. We identified the opportunities it holds early on, and are able to offer patients innovative care services after our market entry into the field of ophthalmology at the beginning of the year.

Right now the basis is being created for new legislation governing outpatient care”, explained the chairman of the Board of Management, Wolfgang Pföhler. This new healthcare provision act has been prompted by the shortage of doctors that is in the offing, especially in rural and structurally weak regions. 

As one of the largest providers of healthcare in Germany, RHÖN-KLINIKUM AG wants to participate in shaping the required system change. And the Company views the integration of outpatient and inpatient care and the creation of attractive working conditions for doctors designed to harmonise family and career as an important first step towards this goal.

“Good health means quality of life, which is the highest human good. In 2011 also, our objective is thus to offer generalised high-quality care that is accessible and affordable for everyone”, said Pföhler.